WEDNESDAY, Sept. 16, 2020 (Healthday News) — A single infusion of an experimental drug dramatically lowers levels of coronavirus in the bodies of newly infected patients and cuts their chances of hospitalization, the drug’s maker reported Wednesday. Eli Lilly’s announcement did not include detailed data and hasn’t been peer-reviewed orContinue Reading

MONDAY, Sept. 14, 2020 (HealthDay News) — More U.S. kids are getting a recommended vaccine that protects against several cancers — but there is still much room for improvement, a new study finds. At issue is the vaccine against human papillomavirus (HPV). Certain strains of HPV are sexually transmitted, andContinue Reading

FRIDAY, Sept. 11, 2020 (HealthDay News) — COVID-19 can damage the kidneys and increase patients’ risk of needing kidney dialysis, researchers report. The study authors also warned that doctors should prepare for a significant rise in chronic kidney disease cases due to the pandemic. For the study, the investigators analyzedContinue Reading

WEDNESDAY, Sept. 9, 2020 (Healthday News) — Final testing of a leading coronavirus vaccine candidate was paused by drugmaker AstraZeneca on Tuesday after a trial volunteer experienced a serious adverse reaction. The company did not release specifics on the case, but whether the reaction was caused by the vaccine orContinue Reading